Clinical Trial Update: Vorinostat for Graft-versus-host Disease (GVHD) Prevention in Non-Malignant Adolescent and Young Adults (AYA) Population [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating vorinostat for prevention of graft-versus-host disease in non-malignant adolescent and young adult patients, currently not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: Sung Won Choi | Conditions: GVHD | Phase 2 | Status: NOT_YET_RECRUITING